BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 16772534)

  • 1. Modulation of signal transducer and activator of transcription 5b activity in breast cancer cells by mutation of tyrosines within the transactivation domain.
    Weaver AM; Silva CM
    Mol Endocrinol; 2006 Oct; 20(10):2392-405. PubMed ID: 16772534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S731 in the transactivation domain modulates STAT5b activity.
    Weaver AM; Silva CM
    Biochem Biophys Res Commun; 2007 Nov; 362(4):1026-30. PubMed ID: 17822672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signal transducer and activator of transcription 5b, c-Src, and epidermal growth factor receptor signaling play integral roles in estrogen-stimulated proliferation of estrogen receptor-positive breast cancer cells.
    Fox EM; Bernaciak TM; Wen J; Weaver AM; Shupnik MA; Silva CM
    Mol Endocrinol; 2008 Aug; 22(8):1781-96. PubMed ID: 18550772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mutant signal transducer and activator of transcription 5b, associated with growth hormone insensitivity and insulin-like growth factor-I deficiency, cannot function as a signal transducer or transcription factor.
    Fang P; Kofoed EM; Little BM; Wang X; Ross RJ; Frank SJ; Hwa V; Rosenfeld RG
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1526-34. PubMed ID: 16464942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen negatively regulates epidermal growth factor (EGF)-mediated signal transducer and activator of transcription 5 signaling in human EGF family receptor-overexpressing breast cancer cells.
    Boerner JL; Gibson MA; Fox EM; Posner ED; Parsons SJ; Silva CM; Shupnik MA
    Mol Endocrinol; 2005 Nov; 19(11):2660-70. PubMed ID: 15976008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signal transducer and activator of transcription 5b: a new target of breast tumor kinase/protein tyrosine kinase 6.
    Weaver AM; Silva CM
    Breast Cancer Res; 2007; 9(6):R79. PubMed ID: 17997837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of c-Src/HER1/STAT5b and HER1/ERK1/2 signaling pathways and cell migration by hexachlorobenzene in MDA-MB-231 human breast cancer cell line.
    Pontillo CA; García MA; Peña D; Cocca C; Chiappini F; Alvarez L; Kleiman de Pisarev D; Randi AS
    Toxicol Sci; 2011 Apr; 120(2):284-96. PubMed ID: 21205633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotensin stimulates mitogenesis of prostate cancer cells through a novel c-Src/Stat5b pathway.
    Amorino GP; Deeble PD; Parsons SJ
    Oncogene; 2007 Feb; 26(5):745-56. PubMed ID: 16862179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STAT5b, a Mediator of Synergism between c-Src and the Epidermal Growth Factor Receptor.
    Kloth MT; Laughlin KK; Biscardi JS; Boerner JL; Parsons SJ; Silva CM
    J Biol Chem; 2003 Jan; 278(3):1671-9. PubMed ID: 12429742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical and functional interactions between Cas and c-Src induce tamoxifen resistance of breast cancer cells through pathways involving epidermal growth factor receptor and signal transducer and activator of transcription 5b.
    Riggins RB; Thomas KS; Ta HQ; Wen J; Davis RJ; Schuh NR; Donelan SS; Owen KA; Gibson MA; Shupnik MA; Silva CM; Parsons SJ; Clarke R; Bouton AH
    Cancer Res; 2006 Jul; 66(14):7007-15. PubMed ID: 16849545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone receptor cytoplasmic domain differentially promotes tyrosine phosphorylation of signal transducers and activators of transcription 5b and 3 by activated JAK2 kinase.
    Yi W; Kim SO; Jiang J; Park SH; Kraft AS; Waxman DJ; Frank SJ
    Mol Endocrinol; 1996 Nov; 10(11):1425-43. PubMed ID: 8923468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EGF receptor-mediated, c-Src-dependent, activation of Stat5b is downregulated in mitogenically responsive hepatocytes.
    Guren TK; Ødegård J; Abrahamsen H; Thoresen GH; Susa M; Andersson Y; Østby E; Christoffersen T
    J Cell Physiol; 2003 Jul; 196(1):113-23. PubMed ID: 12767047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of STAT5b transcriptional activity by ligand-activated peroxisome proliferator-activated receptor (PPAR) alpha and PPARgamma.
    Shipley JM; Waxman DJ
    Mol Pharmacol; 2003 Aug; 64(2):355-64. PubMed ID: 12869640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of signal transducer and activator of transcription (STAT) 5b activation by the temporal pattern of growth hormone stimulation.
    Gebert CA; Park SH; Waxman DJ
    Mol Endocrinol; 1997 Apr; 11(4):400-14. PubMed ID: 9092792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A constitutively active Lck kinase promotes cell proliferation and resistance to apoptosis through signal transducer and activator of transcription 5b activation.
    Shi M; Cooper JC; Yu CL
    Mol Cancer Res; 2006 Jan; 4(1):39-45. PubMed ID: 16446405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of STAT5B phosphorylation correlating with expression of cytokine-inducible SH2-containing protein (CIS).
    Cooper JC; Boustead JN; Yu CL
    Cell Signal; 2006 Jun; 18(6):851-60. PubMed ID: 16125365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basal activation of transcription factor signal transducer and activator of transcription (Stat5) in nonpregnant mouse and human breast epithelium.
    Nevalainen MT; Xie J; Bubendorf L; Wagner KU; Rui H
    Mol Endocrinol; 2002 May; 16(5):1108-24. PubMed ID: 11981045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
    Huang Y; Li X; Jiang J; Frank SJ
    Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein kinase G type Ialpha activity in human ovarian cancer cells significantly contributes to enhanced Src activation and DNA synthesis/cell proliferation.
    Leung EL; Wong JC; Johlfs MG; Tsang BK; Fiscus RR
    Mol Cancer Res; 2010 Apr; 8(4):578-91. PubMed ID: 20371672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor-I receptor signaling in tamoxifen-resistant breast cancer: a supporting role to the epidermal growth factor receptor.
    Knowlden JM; Hutcheson IR; Barrow D; Gee JM; Nicholson RI
    Endocrinology; 2005 Nov; 146(11):4609-18. PubMed ID: 16037379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.